Why Should Investors Attend?
Download the agenda to discover the key opportunities and insights into the evolving obesity and metabolic treatment landscape, unlocking pathways for impactful and strategic investments.
- Understand market dynamics and identify investment opportunities in a sector projected to reach $100 billion by 2034.
- Gain knowledge about the latest breakthroughs, including GLP-1 drug combinations, gene therapies, and digital therapeutics shaping the future of obesity treatment.
- Connect with leaders from biotech, pharma, and health tech to explore strategic partnerships and co-investment possibilities.
- Learn about the regulatory landscape and reimbursement strategies that impact market access and investment timelines.
- Hear from providers and payers on adopting new treatments, aligning investment decisions with real-world needs and outcomes.
